Bank & Trust Company’s AbbVie ABBV Stock Holding History

Bank & Trust Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49M	Hold	5,923	–	–	0.94%	31
2026 Q1	$1.29M	Hold	5,923	–	–	0.87%	32
2025 Q4	$1.35M	Hold	5,923	–	–	0.96%	28
2025 Q3	$1.37M	Hold	5,923	–	–	1.01%	28
2025 Q2	$1.1M	Buy	5,923 +81	+1%	+$15.1K	0.87%	35
2025 Q1	$1.22M	Sell	5,842 -80	-1%	-$15.6K	1%	32
2024 Q4	$1.05M	Hold	5,922	–	–	0.88%	33
2024 Q3	$1.17M	Hold	5,922	–	–	0.95%	30
2024 Q2	$1.02M	Buy	+5,922	New	+$981K	0.86%	32

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Bank & Trust Company's ABBV Position: Q2 2026 in Review

Bank & Trust Company held its AbbVie (ABBV) position steady in Q2 2026 at 5,923 shares worth $1.49M. The position accounts for 0.94% of the portfolio, ranked #31.

Bank & Trust Company first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bank & Trust Company held 5,923 shares of AbbVie worth $1.49M as of Q2 2026.
Bank & Trust Company left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.94% of Bank & Trust Company's portfolio in Q2 2026, its #31 holding.
Bank & Trust Company first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.